Top compounds associated with response to RP11-111K18.1


Feature Type Standardized
Nominal ANOVA
mRNA avrainvillamide CTRPv2 pan-cancer AAC -0.075 0.07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.07
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC -0.14 0.07
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.089 0.07
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.07
mRNA AZD8055 CTRPv2 pan-cancer AAC 0.064 0.07
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.078 0.07
mRNA BRD4132 CTRPv2 pan-cancer AAC 0.068 0.07
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC -0.067 0.07
mRNA semagacestat CTRPv2 pan-cancer AAC -0.066 0.08
Download CSV